Outset Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	36.44	124.01	68.51	73.22	182.35	294.97
Short-Term Investments	142.2	34.67	134.82	214.28	157.14	19.9
Cash & Short-Term Investments	178.64	158.69	203.32	287.5	339.49	314.87
Cash Growth	1.71%	-21.95%	-29.28%	-15.31%	7.82%	349.31%
Receivables	32.96	35.62	32.98	28.07	25.6	6.47
Inventory	49.29	59.39	49.22	51.48	39.19	18.38
Prepaid Expenses	4.48	4.53	5.7	6.6	5.53	6.19
Total Current Assets	265.37	258.22	291.22	373.65	409.8	345.91
Property, Plant & Equipment	8.02	12.07	18.65	21.99	20.2	23.25
Other Long-Term Assets	3.87	5.5	3.93	4.48	33.47	34.67
Total Assets	277.26	275.8	313.8	400.12	463.46	403.83
Accounts Payable	1.72	3.86	5.83	0.6	1.76	4.95
Accrued Expenses	13.99	21.94	26.7	30.64	34.72	23.35
Current Portion of Leases	1.91	1.8	1.59	1.32	1.15	0.88
Current Unearned Revenue	14.9	12.75	11.73	8.66	6.34	3.2
Other Current Liabilities	4.92	5.03	9.47	10.73	7.72	4.31
Total Current Liabilities	37.45	45.38	55.32	51.95	51.7	36.69
Long-Term Debt	95.52	197.38	130.11	96.34	29.76	29.67
Long-Term Leases	1.24	2.68	4.48	5.58	6.89	8.04
Long-Term Unearned Revenue	0.68	0.84	0.1	0.15	0.31	0.57
Other Long-Term Liabilities	-	2.7	0.9	0.11	0.72	0.24
Total Liabilities	134.89	248.98	190.92	154.13	89.38	75.22
Common Stock	0.02	0.05	0.05	0.05	0.05	0.04
Additional Paid-In Capital	1,290	1,116	1,085	1,035	1,000	822.62
Retained Earnings	-1,152	-1,090	-961.75	-788.95	-625.99	-494.06
Comprehensive Income & Other	0.16	0.04	0.07	-0.56	-0.18	0
Total Common Equity	138.52	26.82	122.89	245.99	374.08	328.61
Shareholders' Equity	142.37	26.82	122.89	245.99	374.08	328.61
Total Liabilities & Equity	277.26	275.8	313.8	400.12	463.46	403.83
Total Debt	98.68	201.86	136.19	103.23	37.81	38.6
Net Cash (Debt)	79.96	-43.17	67.14	184.27	301.68	276.27
Net Cash Growth	-	-	-63.57%	-38.92%	9.20%	652.31%
Net Cash Per Share	6.92	-12.47	20.31	57.39	99.26	253.33
Filing Date Shares Outstanding	18.15	3.59	3.37	3.24	3.16	2.85
Total Common Shares Outstanding	17.81	3.53	3.35	3.23	3.15	2.85
Working Capital	227.92	212.84	235.9	321.7	358.11	309.22
Book Value Per Share	7.78	7.60	36.63	76.13	118.78	115.38
Tangible Book Value	138.52	26.82	122.89	245.99	374.08	328.61
Tangible Book Value Per Share	7.78	7.60	36.63	76.13	118.78	115.38
Machinery	-	18.6	18.73	16.16	12.47	9.03
Construction In Progress	-	0.64	0.77	4.77	0.87	1.34
Leasehold Improvements	-	9.69	9.62	5.04	4.86	4.46

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q